Health Condition 1: F330- Major depressive disorder, recurrent, mild Health Condition 2: F331- Major depressive disorder, recurrent, moderate Health Condition 3: F320- Major depressive disorder, singleepisode, mild Health Condition 4: F321- Major depressive disorder, singleepisode, moderate
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: A. Elderly people with depression of not less than two weeks duration, with a minimum of two typical and two common symptoms will be included in the study. • Typical symptoms: o Depressed mood o Loss of interest and enjoyment. o Increased fatigability and diminished activity • Common symptoms: o Reduced concentration and attention. o Reduced self-esteem and self-confidence. o Guilt feeling and unworthiness (mild type of episode) o Bleak and pessimistic view of the future. o Disturbed Sleep o Diminished appetite B. Age above 60 years C. Mild and moderate depression [HDRS score - 8-13 mild, 14-18 moderate] D. GDS-15 score more than 5 E. Participants having prior experience or knowledge of the treatment; e.g., primed to expect ‘homoeopathic aggravation’ and available treatment options for the disease conditions, intimated through Patient Information Sheet.
Exclusion criteria
Exclusion criteria: A. Mood disturbance when associated with bipolar affective disorder, schizophrenia, schizophreniform disorder, schizoaffective disorder, or psychotic disorder. B. Severe dementia (MoCA score less than 10) C. Currently receiving any effective anti-depressant. D. Active suicidal E. Uncontrolled systemic disorders. F. Undergoing homoeopathic treatment for any chronic disease within the last six months. G. Vulnerable population- Unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, mentally incompetent people. H. Self-reported immune-compromised state. I. Patients with the habit of tobacco chewing and/or smoking, alcoholism, and/or any other form(s) of substance abuse and/or dependence. J. Simultaneous participation in any other clinical trials K. Not Providing with written informed consent to participate voluntarily
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hamilton Depression Rating Scale (HDRS 17)Timepoint: Baseline, every month, up to 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Measure Yourself Medical Outcome Profile-2 (MYMOP-2)Timepoint: Baseline, every month, up to 3 months;Geriatric Depression Scale 15 (GDS-15)Timepoint: Baseline, every month, up to 3 months | — |
Countries
India
Contacts
D. N. De Homoeopathic Medical College and Hospital